Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Melanoma Management|September 8, 2018
Adjuvant treatment for stage III melanoma in the era of targeted medicine and immunotherapyEytan Ben-Ami, Jacob SchachterExpert Opinion on Drug Safety|February 12, 2016
A safety evaluation of imatinib mesylate in the treatment of gastrointestinal stromal tumorEytan Ben Ami, George D DemetriOncology Letters|July 31, 2012
Multidisciplinary management of very advanced stage III and IV melanoma: Proof-of-principleHaim Gutman, Eytan Ben-Ami, Roni Shapira-Frommer, et al.Journal of Oncology Practice|May 1, 2014
Involvement of the family physician in the care of chemotherapy-treated patients with cancer: patients' perspectivesEytan Ben-Ami, Hadar Merom, Fabienne Sikron, et al.Acta Oncologica (Stockholm, Sweden)|August 11, 2021
Thyroid dysfunction and survival in cancer patients treated with immune checkpoint inhibitors: analyses from a large single tertiary cancer center databaseRuth Percik, Yair Liel, Damien Urban, et al.BMC Cancer|August 8, 2018
Safety and tolerability of quizartinib, a FLT3 inhibitor, in advanced solid tumors: a phase 1 dose-escalation trialKyriakos P Papadopoulos, Eytan Ben-Ami, Amita Patnaik, et al.Anti-Cancer Drugs|August 11, 2018
Imatinib-induced drug reaction with eosinophilia and systemic symptoms in solid tumors: a patient with dermatofibrosarcoma protuberans and successful desensitization managementEytan Ben-Ami, Maria C Castells, Nathan T Connell, et al.Journal of Surgical Oncology|June 27, 2017
Perioperative BRAF inhibitors in locally advanced stage III melanomaDouglas Zippel, Gal Markel, Roni Shapira-Frommer, et al.Surgical Oncology|April 20, 2023
IOeRT in retroperitoneal sarcoma: Towards more organ preservation with comparable oncological outcomesEyal Mor, Dan Assaf, Shanie Shemla, et al.Plos One|March 2, 2013
Nicotinamide inhibits vasculogenic mimicry, an alternative vascularization pathway observed in highly aggressive melanomaOrit Itzhaki, Eyal Greenberg, Bruria Shalmon, et al.Pageof 3